Missouri 2023 Regular Session

Missouri Senate Bill SB659 Latest Draft

Bill / Introduced Version

                             
FIRST REGULAR SESSION 
SENATE BILL NO. 659 
102ND GENERAL ASSEMBLY  
INTRODUCED BY SENATOR MCCREERY. 
2427S.01I 	KRISTINA MARTIN, Secretary  
AN ACT 
To repeal section 338.010, RSMo, and to enact in lieu thereof two new sections relating to 
contraceptives. 
 
Be it enacted by the General Assembly of the State of Missouri, as follows: 
     Section A.  Section 338.010, RSMo, is repealed and two new 1 
sections enacted in lieu thereof, to be known as sections 2 
338.010 and 338.720, to read as follows:3 
     338.010.  1.  The "practice of pharmacy" means the 1 
interpretation, implementation, and evaluation of medical 2 
prescription orders, including any l egend drugs under 21 3 
U.S.C. Section 353; the receipt, transmission, or handling 4 
of such orders or facilitating the dispensing of such 5 
orders; the designing, initiating, implementing, and 6 
monitoring of a medication therapeutic plan as defined by 7 
the prescription order so long as the prescription order is 8 
specific to each patient for care by a pharmacist; the 9 
compounding, dispensing, labeling, and administration of 10 
drugs and devices pursuant to medical prescription orders 11 
and administration of viral influenza, pneumonia, shingles, 12 
hepatitis A, hepatitis B, diphtheria, tetanus, pertussis, 13 
and meningitis vaccines by written protocol authorized by a 14 
physician for persons at least seven years of age or the age 15 
recommended by the Centers for Disease Co ntrol and  16 
Prevention, whichever is higher, or the administration of 17 
pneumonia, shingles, hepatitis A, hepatitis B, diphtheria, 18   SB 659 	2 
tetanus, pertussis, meningitis, and viral influenza vaccines 19 
by written protocol authorized by a physician for a specific 20 
patient as authorized by rule; the participation in drug 21 
selection according to state law and participation in drug 22 
utilization reviews; the proper and safe storage of drugs 23 
and devices and the maintenance of proper records thereof; 24 
consultation with pat ients and other health care 25 
practitioners, and veterinarians and their clients about 26 
legend drugs, about the safe and effective use of drugs and 27 
devices; the prescribing and dispensing of any nicotine 28 
replacement therapy product under section 338.665; the  29 
dispensing of HIV postexposure prophylaxis pursuant to 30 
section 338.730; the dispensing of self -administered  31 
hormonal contraceptives under section 338.720; and the  32 
offering or performing of those acts, services, operations, 33 
or transactions necessar y in the conduct, operation, 34 
management and control of a pharmacy.  No person shall  35 
engage in the practice of pharmacy unless he or she is 36 
licensed under the provisions of this chapter.  This chapter  37 
shall not be construed to prohibit the use of auxili ary  38 
personnel under the direct supervision of a pharmacist from 39 
assisting the pharmacist in any of his or her duties.  This  40 
assistance in no way is intended to relieve the pharmacist 41 
from his or her responsibilities for compliance with this 42 
chapter and he or she will be responsible for the actions of 43 
the auxiliary personnel acting in his or her assistance.   44 
This chapter shall also not be construed to prohibit or 45 
interfere with any legally registered practitioner of 46 
medicine, dentistry, or podiatry, or veterinary medicine 47 
only for use in animals, or the practice of optometry in 48 
accordance with and as provided in sections 195.070 and 49   SB 659 	3 
336.220 in the compounding, administering, prescribing, or 50 
dispensing of his or her own prescriptions. 51 
     2.  Any pharmacist who accepts a prescription order for 52 
a medication therapeutic plan shall have a written protocol 53 
from the physician who refers the patient for medication 54 
therapy services.  The written protocol and the prescription 55 
order for a medication th erapeutic plan shall come from the 56 
physician only, and shall not come from a nurse engaged in a 57 
collaborative practice arrangement under section 334.104, or 58 
from a physician assistant engaged in a collaborative 59 
practice arrangement under section 334.73 5. 60 
     3.  Nothing in this section shall be construed as to 61 
prevent any person, firm or corporation from owning a 62 
pharmacy regulated by sections 338.210 to 338.315, provided 63 
that a licensed pharmacist is in charge of such pharmacy. 64 
     4.  Nothing in this section shall be construed to apply 65 
to or interfere with the sale of nonprescription drugs and 66 
the ordinary household remedies and such drugs or medicines 67 
as are normally sold by those engaged in the sale of general 68 
merchandise. 69 
     5.  No health carrier as defined in chapter 376 shall 70 
require any physician with which they contract to enter into 71 
a written protocol with a pharmacist for medication 72 
therapeutic services. 73 
     6.  This section shall not be construed to allow a 74 
pharmacist to diagno se or independently prescribe 75 
pharmaceuticals. 76 
     7.  The state board of registration for the healing 77 
arts, under section 334.125, and the state board of 78 
pharmacy, under section 338.140, shall jointly promulgate 79 
rules regulating the use of protocols for prescription  80 
orders for medication therapy services and administration of 81   SB 659 	4 
viral influenza vaccines.  Such rules shall require 82 
protocols to include provisions allowing for timely 83 
communication between the pharmacist and the referring 84 
physician, and any other patient protection provisions 85 
deemed appropriate by both boards.  In order to take effect, 86 
such rules shall be approved by a majority vote of a quorum 87 
of each board.  Neither board shall separately promulgate 88 
rules regulating the use of prot ocols for prescription 89 
orders for medication therapy services and administration of 90 
viral influenza vaccines.  Any rule or portion of a rule, as 91 
that term is defined in section 536.010, that is created 92 
under the authority delegated in this section shal l become  93 
effective only if it complies with and is subject to all of 94 
the provisions of chapter 536 and, if applicable, section 95 
536.028.  This section and chapter 536 are nonseverable and 96 
if any of the powers vested with the general assembly 97 
pursuant to chapter 536 to review, to delay the effective 98 
date, or to disapprove and annul a rule are subsequently 99 
held unconstitutional, then the grant of rulemaking 100 
authority and any rule proposed or adopted after August 28, 101 
2007, shall be invalid and void. 102 
    8.  The state board of pharmacy may grant a certificate 103 
of medication therapeutic plan authority to a licensed 104 
pharmacist who submits proof of successful completion of a 105 
board-approved course of academic clinical study beyond a 106 
bachelor of science i n pharmacy, including but not limited 107 
to clinical assessment skills, from a nationally accredited 108 
college or university, or a certification of equivalence 109 
issued by a nationally recognized professional organization 110 
and approved by the board of pharmacy . 111 
     9.  Any pharmacist who has received a certificate of 112 
medication therapeutic plan authority may engage in the 113   SB 659 	5 
designing, initiating, implementing, and monitoring of a 114 
medication therapeutic plan as defined by a prescription 115 
order from a physician that is specific to each patient for 116 
care by a pharmacist. 117 
     10.  Nothing in this section shall be construed to 118 
allow a pharmacist to make a therapeutic substitution of a 119 
pharmaceutical prescribed by a physician unless authorized 120 
by the written protocol or the physician's prescription 121 
order. 122 
     11.  "Veterinarian", "doctor of veterinary medicine", 123 
"practitioner of veterinary medicine", "DVM", "VMD", "BVSe", 124 
"BVMS", "BSe (Vet Science)", "VMB", "MRCVS", or an 125 
equivalent title means a person who has received a doctor's 126 
degree in veterinary medicine from an accredited school of 127 
veterinary medicine or holds an Educational Commission for 128 
Foreign Veterinary Graduates (EDFVG) certificate issued by 129 
the American Veterinary Medical Association (AVMA). 130 
     12.  In addition to other requirements established by 131 
the joint promulgation of rules by the board of pharmacy and 132 
the state board of registration for the healing arts: 133 
     (1)  A pharmacist shall administer vaccines by protocol 134 
in accordance with treatment guidelines established by the 135 
Centers for Disease Control and Prevention (CDC); 136 
     (2)  A pharmacist who is administering a vaccine shall 137 
request a patient to remain in the pharmacy a safe amount of 138 
time after administering the vaccine to observe any adverse 139 
reactions.  Such pharmacist shall have adopted emergency 140 
treatment protocols; 141 
     (3)  In addition to other requirements by the board, a 142 
pharmacist shall receive additional training as required by 143 
the board and evidenced by receivi ng a certificate from the 144   SB 659 	6 
board upon completion, and shall display the certification 145 
in his or her pharmacy where vaccines are delivered. 146 
     13.  A pharmacist shall inform the patient that the 147 
administration of the vaccine will be entered into the 148 
ShowMeVax system, as administered by the department of 149 
health and senior services.  The patient shall attest to the 150 
inclusion of such information in the system by signing a 151 
form provided by the pharmacist.  If the patient indicates 152 
that he or she does no t want such information entered into 153 
the ShowMeVax system, the pharmacist shall provide a written 154 
report within fourteen days of administration of a vaccine 155 
to the patient's health care provider, if provided by the 156 
patient, containing: 157 
     (1)  The identity of the patient; 158 
     (2)  The identity of the vaccine or vaccines 159 
administered; 160 
     (3)  The route of administration; 161 
     (4)  The anatomic site of the administration; 162 
     (5)  The dose administered; and 163 
     (6)  The date of administration. 164 
     338.720.  1.  For purposes of this section, "self - 1 
administered hormonal contraceptive" shall mean a drug 2 
composed of a combination of hormones that is approved by 3 
the Food and Drug Administration to prevent pregnancy. 4 
     2.  A pharmacist may dispense self -administered  5 
hormonal contraceptives to a person under a prescription 6 
order for medication therapy services as described in 7 
section 338.010.  A prescription order for a self - 8 
administered hormonal contraceptive shall have no exp iration  9 
date. 10 
     3.  The board of pharmacy, under section 338.140, and 11 
the board of registration for the healing arts, under 12   SB 659 	7 
section 334.125, shall jointly promulgate rules regulating 13 
the use of protocols for prescription orders for self - 14 
administered hormonal contraceptives.  Any rule or portion 15 
of a rule, as that term is defined in section 536.010, that 16 
is created under the authority delegated in this section 17 
shall become effective only if it complies with and is 18 
subject to all of the provisions of chapter 536 and, if 19 
applicable, section 536.028.  This section and chapter 536 20 
are nonseverable, and if any of the powers vested with the 21 
general assembly pursuant to chapter 536 to review, to delay 22 
the effective date, or to disapprove and annul a rule are  23 
subsequently held unconstitutional, then the grant of 24 
rulemaking authority and any rule proposed or adopted after 25 
August 28, 2023, shall be invalid and void. 26 
     4.  The rules adopted under this section shall require 27 
a pharmacist to: 28 
     (1)  Complete a training program approved by the board 29 
of pharmacy that is related to dispensing self -administered  30 
hormonal contraceptives under this section; 31 
     (2)  Provide a self-screening risk assessment tool that 32 
the patient shall use prior to the p harmacist's dispensing 33 
the self-administered hormonal contraceptive under this 34 
section; 35 
     (3)  At least once every twelve months, verbally refer 36 
the patient to the health care provider with whom the 37 
pharmacist has a prescription order before dispens ing the  38 
self-administered hormonal contraceptive to the patient; 39 
     (4)  Provide the patient with a written record of the 40 
self-administered hormonal contraceptive dispensed and 41 
advise the patient to consult with a health care provider; 42 
and 43   SB 659 	8 
     (5)  Dispense the self-administered hormonal 44 
contraceptive to the patient as soon as practicable. 45 
     5.  All state and federal laws governing insurance 46 
coverage of contraceptive drugs, devices, products, and 47 
services shall apply to self -administered hormonal  48 
contraceptives dispensed by a pharmacist under this section. 49 
     6.  The provisions of this section shall terminate upon 50 
the enactment of any laws allowing the provision of hormonal 51 
contraceptives from a pharmacist without a prescription. 52 
     7.  Nothing in this section shall be construed to allow 53 
a pharmacist to make a therapeutic substitution of a 54 
pharmaceutical prescribed by a physician unless authorized 55 
by the written protocol or the physician's written 56 
prescription order. 57 
